DANIEL G WELCH Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
Get free email notifications about insider trading for DANIEL G WELCH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL G WELCH. DANIEL G WELCH is CEO and President in INTERMUNE INC ($ITMN) and Chairman, CEO and President in INTERMUNE INC ($ITMN) and President & CEO in INTERMUNE INC ($ITMN) and President and CEO in INTERMUNE INC ($ITMN) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in HYPERION THERAPEUTICS INC ($HPTX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in AveXis, Inc. ($AVXS) and Director in Nuvation Bio Inc. ($PANA).
DANIEL G WELCH in INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL G WELCH: Director
Holdings: 8,060 shares
Current Value: $915,374
Latest Transaction: Jun 01 2020
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL G WELCH in INTERCEPT PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVXS, HPTX, ICPT, ITMN, NUVB, SGEN, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 72.74 | 2,966 | 215,747 | 2,966 | |
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,595 | 0 | 8,060 | 6.5 K to 8.1 K (+24.67 %) |
| Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 82.25 | 2,174 | 178,812 | 2,174 | |
| Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,570 | 0 | 6,465 | 4.9 K to 6.5 K (+32.07 %) |
| Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
| Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,787 | 0 | 4,895 | 3.1 K to 4.9 K (+57.50 %) |
| Aug 02 2017 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Sell | S | 123.93 | 602 | 74,604 | 3,108 | 3.7 K to 3.1 K (-16.23 %) |
| Jul 21 2017 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Sell | S | 126.76 | 217 | 27,507 | 3,710 | 3.9 K to 3.7 K (-5.53 %) |
| Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 122.01 | 2,036 | 248,412 | 2,036 | |
| Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,423 | 0 | 3,927 | 2.5 K to 3.9 K (+56.83 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,204 | 0 | 2,504 | 1.3 K to 2.5 K (+92.62 %) |
| Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 183.62 | 3,500 | 642,670 | 3,500 | |
| Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,300 | 0 | 1,300 | 0 to 1.3 K |
Page: 1